Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
Global Transdermal Drug Delivery Market to 2020

Global Transdermal Drug Delivery Market to 2020

Date Published: Feb 13 2015

Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

$3,400.00
Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Feb 1 2015
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00
Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Feb 1 2015
The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies
 

Description

$3,495.00
Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Feb 1 2015
The Distribution Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies.
 

Description

$3,495.00
Drug Delivery Partnering Terms and Agreements

Drug Delivery Partnering Terms and Agreements

Date Published: Feb 1 2015
The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies
 

Description

$3,495.00
Diagnostics Partnering Terms and Agreements

Diagnostics Partnering Terms and Agreements

Date Published: Feb 1 2015
The Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies.
$3,495.00
Vaccine Partnering Terms and Agreements

Vaccine Partnering Terms and Agreements

Date Published: Feb 1 2015
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Global Pharma US & EU Outlook 2015  : First –In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies

Global Pharma US & EU Outlook 2015 : First –In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies

Date Published: Jan 26 2015
Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition.
 
$2,000.00
New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

Date Published: Jan 20 2015
The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous efforts by the JP government to promote increased use of generics (started in 2006 by launching various benefits for GE use at Pharmacy, hospital level) – now in 2014, Generic penetration of small molecules is changing the trend line and moving towards faster market penetration.
$4,000.00
Cefditoren  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Cefditoren - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Jan 19 2015

Cefditoren - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Treatment of mild to moderate infections caused by microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia pharyngitis/tonsillitis; Treatment of uncomplicated skin and skin-structure infections Cornerstone (Spectracef); Purdue (Spectracef)

$600.00
Enzalutamide  - Comprehensive patent search

Enzalutamide - Comprehensive patent search

Date Published: Jan 19 2015

Enzalutamide - Comprehensive patent search Treatment of metastatic castration-resistant prostate cancer Medivation (MDV3100); Astellas Pharma (Xtandi)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Ambrisentan   - Comprehensive patent search

Ambrisentan - Comprehensive patent search

Date Published: Jan 19 2015

Ambrisentan - Comprehensive patent search Treatment of pulmonary arterial hypertension Gilead (Letairis); Glaxosmithkline (Volibris)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Venlafaxine  - Comprehensive patent search

Venlafaxine - Comprehensive patent search

Date Published: Jan 19 2015

Venlafaxine - Comprehensive patent search Depression; Generalised anxiety disorder Wyeth (Effexor, Efexor)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$6,200.00
Erlotinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Erlotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Jan 19 2015

Erlotinib - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Non-small cell lung cancer OSI Pharm (Tarceva); Roche (Tarceva); Hoffmann-La Roche (Tarceva)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$1,400.00
Infliximab  - Comprehensive patent search

Infliximab - Comprehensive patent search

Date Published: Jan 19 2015

Infliximab - Comprehensive patent search Rheumatoid arthritis in combination with Methotrexate; Psoriatic arthritis, optionally in combination with Methotrexate; Ankylosing spondylitis; Crohn's disease; Psoriasis; Ulcerative colitis Schering-Plough (Remicade); Centocor (Remicade)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$9,300.00
Ciprofloxacin  - Comprehensive patent search

Ciprofloxacin - Comprehensive patent search

Date Published: Jan 19 2015

Ciprofloxacin - Comprehensive patent search Urinary tract infections, bronchitis, sinusitis, cystitis, prostatitis, diarrhoea, typhoid, gonorrhoea corneal ulcers, superficial bacterial infections of the eye and adnexa. Bayer (Cipro, Ciproxin) ; Alcon (Cipro, Ciloxan, Ciprodex)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00
Metformin, Canagliflozin - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Metformin, Canagliflozin - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries)

Date Published: Jan 19 2015

Metformin, Canagliflozin - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Adjunctive therapy to diet and exercise to improve glycaemic control in patients with type 2 diabetes Janssen (Invokamet, Vokanamet)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$1,400.00
Memantine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Memantine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Jan 19 2015

Memantine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) Treatment of Alzheimer's disease Forest Labs (Namenda); Lundbeck (Ebixa)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$600.00
Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date Published: Jan 19 2015

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (50 countries) Treatment and prevention of osteoporosis in postmenopausal women Roche (Boniva, Bondronat)

Report Summary
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

$1,400.00
Imatinib  - Comprehensive patent search

Imatinib - Comprehensive patent search

Date Published: Jan 19 2015

Imatinib - Comprehensive patent search Chronic myeloid leukaemia; acute lymphoblastic leukaemia; Kit (CD117)-positive malignant gastro-intestinal stromal tumours (GIST); dermatofibrosarcoma protuberans Novartis (Gleevec, Glivec)

Report Summary
Imagine having your own team of pharmaceutical patent experts at the click of a button.

$7,500.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data